Sporotrichosis pathophysiology

Jump to navigation Jump to search

Sporotrichosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sporotrichosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Treatment

Medical Therapy

Surgery

Prevention

Case Studies

Case #1

Sporotrichosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sporotrichosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sporotrichosis pathophysiology

CDC on Sporotrichosis pathophysiology

Sporotrichosis pathophysiology in the news

Blogs on Sporotrichosis pathophysiology

Directions to Hospitals Treating Sporotrichosis

Risk calculators and risk factors for Sporotrichosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alison Leibowitz [2]

Overview

Pathophysiology

Transmission

  • S. schenckii is usually transmitted to the human host via posttraumatic inoculation. However, sporotrichosis may also develop as a result of spore inhalation, although this mode of transmission is infrequent.
  • Modes of transmission either lead to direct inoculation or enable the entry of the fungus.
  • Actions, such as handling thorny plants, sphagnum moss, bales of hay, or any plant or plant product that can cause skin trauma, may enable S. schenckii entry.

Pathogenesis

  • The pathophysiology of sporotrichosis depends on the histological subtype and the frequently nonspecific histopathology may mimic other granulomatous diseases.[1]
  • S. schenckii is capable of modulating the immune response to promote its own survival by blocking cytokine production by macrophages.[2]

Cutaneous forms

  • S. schecknii accesses the subcutaneous tissue following minor epidermal trauma.
  • S. schecknii, a thermo-dependent fungus, converts into its yeast form upon entering the tissue.
  • Fixed form
    • The yeast form of S. schenckii stays localized in subcutaneous tissue
  • Lymphocutaneous form
    • The yeast form of S. schenckii extends through the nearby lymphatic vessels
  • Disseminated cutaneous form
    • Manifests upon the hematogenous dissemination of the yeast form of S. schenckii.

Extracutaneous/Systematic Forms

  • Osteoarticular form
    • May manifest upon contiguity or hematogenous spread.
  • Pulmonary form
    • Manifests following inhalation of S. schenckii spores
  • Disseminated form
    • Manifests upon the hematogenous dissemination of the yeast form of S. schenckii.[3]

References

  1. Mahajan VK (2014). "Sporotrichosis: an overview and therapeutic options". Dermatol Res Pract. 2014: 272376. doi:10.1155/2014/272376. PMC 4295339. PMID 25614735.
  2. Carlos IZ, Sassá MF, da Graça Sgarbi DB, Placeres MC, Maia DC (July 2009). "Current research on the immune response to experimental sporotrichosis". Mycopathologia. 168 (1): 1–10. doi:10.1007/s11046-009-9190-z. PMID 19241140.
  3. Barros MB, de Almeida Paes R, Schubach AO (2011). "Sporothrix schenckii and Sporotrichosis". Clin Microbiol Rev. 24 (4): 633–54. doi:10.1128/CMR.00007-11. PMC 3194828. PMID 21976602.